Images (3)

Ipratropium bromide

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

Last updated on: 29.10.2020

Synonym(s)

8-Methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]oct-3-yl]-3-hydroxy-2-phenyl-propanoatium bromide; CAS number: 22254-24-6 (Ipratropiumbromid); CAS number: 60205-81-4; CAS number: 66985-17-9; Muscarinic receptor antagonist; N-(2-propyl)atropinium bromide; Parasympatholytic

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Anticholinergic, bronchodilator.

Half-lifeThis section has been translated automatically.

3,2 h

Pharmacodynamics (Effect)This section has been translated automatically.

Competitive antagonism of acetylcholine at the muscarinic receptor.

IndicationThis section has been translated automatically.

Bronchial asthma, chronic obstructive bronchitis (COPD). Note:In the therapy of bronchial asthma the substance, like other muscarinic receptor antagonists, is hardly used any more.

Limited indicationThis section has been translated automatically.

Pregnancy, nursing, tachyarrhythmia.

Dosage and method of useThis section has been translated automatically.

3-4 times/day 1-2 strokes per inhalation, max. 12 strokes/day.

Undesirable effectsThis section has been translated automatically.

Allergic reactions, accommodation disorders, micturition disorders, dry mouth, glaucoma, bronchospasm.

InteractionsThis section has been translated automatically.

Enhancement of the effect of β sympathomimetics and theophylline, enhanced anticholinergic effect in anticholinergic drugs, neuroleptics and tricyclic antidepressants

ContraindicationThis section has been translated automatically.

Hypersensitivity to the active substance or atropine and its derivatives, narrow-angle glaucoma, prostate hypertrophy.

PreparationsThis section has been translated automatically.

Authors

Last updated on: 29.10.2020

Authors: Prof. Dr. med. Peter Altmeyer Prof. Dr. med. Martina Bacharach-Buhles